All posts by: Michael Zand

Un nuevo bisturí molecular actúa como un GPS para mejorar la edición genética – PanamaOn

Pharma IQ: Cell & Gene Therapy Manufacturing Summit – PR Newswire (press release)

Pharma IQ: Cell & Gene Therapy Manufacturing SummitPR Newswire (press release)The Cell & Gene Therapy Manufacturing Summit is the only conference that is 100% dedicated to focusing on development of manufacturing processes for cell & gene p… Continue reading

The trickiest family tree in biology : Nature News & Comment – Nature.com

Nature.comThe trickiest family tree in biology : Nature News & CommentNature.comScientists are striving for a deeper view of development, from embryo to adult, cell-by-cell.and more &raquo… Continue reading

Cancer Gene Therapy Market : Share, Growth, Trends and Forecast by 2025 – Medgadget (blog)

Cancer Gene Therapy Market : Share, Growth, Trends and Forecast by 2025Medgadget (blog)When the aforementioned therapies fail to achieve desired results, gene therapy is leveraged. Gene therapy involves the insertion of a functional gene, also known as… Continue reading

Colonic organoids for drug testing and colorectal disease modelling – Nature.com

Nature.comColonic organoids for drug testing and colorectal disease modellingNature.comThe possibility of obtaining gastric and small intestine organoids from human pluripotent stem cells (PSCs) has greatly facilitated the study of gastrointestinal dev… Continue reading

CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model. – UroToday

CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model.UroTodayY sequence by immunofluorescence. We assessed functions of GPRC6A in PC-3 cells expressing endogenous GPRC6A and in GPRC6A-deficient PC-3 cells … Continue reading